Deepbridge Capital logo

Deepbridge Capital

Europe, Cheshire, United Kingdom, Chester

Description

Deepbridge Capital is a UK-based venture capital firm and investment manager headquartered in Chester, specializing in tax-efficient investments, primarily through Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS) funds. The firm focuses on identifying and supporting disruptive early-stage companies across the UK, with a particular emphasis on the technology and life sciences sectors. Their investment strategy is centered on providing growth capital to businesses with strong intellectual property and scalable business models, aiming to generate significant returns for investors while contributing to the growth of the UK's innovation economy.

Deepbridge distinguishes itself by offering a structured approach to venture capital, making it accessible to a broader range of investors through its EIS and SEIS funds. These funds pool capital from high-net-worth individuals and retail investors, which is then strategically deployed into a diversified portfolio of qualifying companies. The firm’s due diligence process is rigorous, focusing on the commercial viability of technologies, the strength of management teams, and the potential for market disruption. This systematic approach helps mitigate some of the inherent risks associated with early-stage investing, aligning with the tax-efficient nature of the schemes they operate.

Since its inception, Deepbridge Capital has demonstrated a significant commitment to the UK's innovation landscape. The firm has successfully deployed over £200 million into growth-focused technology and life sciences companies across the UK, underscoring its substantial impact on the sector. This capital has been distributed across a diverse portfolio, with Deepbridge having invested in over 40 companies to date. Typical first cheques from Deepbridge Capital into a company range from approximately $1,016,000 to $5,080,000, reflecting their role in leading or co-leading significant early-stage and growth rounds. Their ongoing support often extends beyond initial funding, providing strategic guidance to help portfolio companies scale and achieve their commercial objectives.

Investor Profile

Deepbridge Capital has backed more than 84 startups, with 4 new investments in the last 12 months alone. The firm has led 60 rounds, about 71% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in United Kingdom, United States, Spain.
  • Strong thematic focus on Health Care, Biotechnology, Medical.
  • Led 1 rounds in the past year.
  • Typical check size: $1.0M – $5.1M.

Stage Focus

  • Seed (55%)
  • Series Unknown (23%)
  • Series A (11%)
  • Pre Seed (7%)
  • Series B (2%)
  • Private Equity (1%)
  • Corporate Round (1%)

Country Focus

  • United Kingdom (93%)
  • United States (2%)
  • Spain (1%)
  • Australia (1%)
  • Singapore (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Software
  • Medical Device
  • Wellness
  • Manufacturing
  • Therapeutics
  • Life Science
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Deepbridge Capital frequently co-invest with?

GM&C Life Sciences Fund
Europe, Cheshire, United Kingdom, Alderley Edge
Co-Investments: 2
The North West Fund
Europe, Warrington, United Kingdom, Warrington
Co-Investments: 2
Juno Capital Partners
Europe, England, United Kingdom, London
Co-Investments: 3
The Welsh Government
Europe, Cardiff, United Kingdom, Cardiff
Co-Investments: 2
Scottish Investment Bank
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 2
QUBIS
Europe, Belfast, United Kingdom, Belfast
Co-Investments: 2
Catapult Ventures
Europe, Leicester, United Kingdom, Enderby
Co-Investments: 2
C
Europe, Belfast, United Kingdom, Belfast
Co-Investments: 2
Scottish Enterprise
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 3
Praetura Ventures
Europe, Manchester, United Kingdom, Manchester
Co-Investments: 3

Which angels does Deepbridge Capital often collaborate with?

Andrew R Banks
Oceania, New South Wales, Australia, Sydney
Shared Deals: 1
DM
Europe, England, United Kingdom, London
Shared Deals: 1
CH
Europe, England, United Kingdom, London
Shared Deals: 2
Mark Livings
Oceania, New South Wales, Australia, Sydney
Shared Deals: 2
NR
Europe, England, United Kingdom, London
Shared Deals: 1
MI
Europe, England, United Kingdom, London
Shared Deals: 2
TT
North America, New York, United States, New York
Shared Deals: 1
Shared Deals: 2
GD
Europe, Hainaut, Belgium, Vaulx-lez-tournai
Shared Deals: 1
LS
Europe, England, United Kingdom, London
Shared Deals: 1

What are some of recent deals done by Deepbridge Capital?

upLYFT

London, England, United Kingdom

upLYFT is working on the next generation of smart wearables to help with musculoskeletal issues related with ageing.

FitnessHealth CareWellness
SeedJul 11, 2025
Amount Raised: $677,473
Spotlight Pathology

Manchester, Manchester, United Kingdom

Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.

Artificial Intelligence (AI)Medical
SeedApr 29, 2025
Amount Raised: $569,838

GeneralPractice.AI is an advanced, AI-powered platform designed to transform primary care and general practice by streamlining workflows.

Health CareHospitalSoftwareWeb Design
SeedApr 11, 2025
Amount Raised: $327,050
HeadBox

London, England, United Kingdom

HeadBox is an online marketplace for inspiring meeting, offsite and event spaces.

E-CommerceEvent ManagementEventsInternetMarketplace
Series UnknownApr 3, 2025
Amount Raised: $3,927,848
AI-Sight

London, England, United Kingdom

AI-Sight is a startup that is developing an AI diabetic retinal screening system to deliver WHO-recommended diabetic eye screening services.

HospitalMedicalMedical Device
SeedSep 19, 2024
Microplate Dx

Glasgow, Glasgow City, United Kingdom

Microplate Dx is a developer of diagnostic technology aimed at significantly reducing fatalities caused by drug-resistant infections.

BiotechnologyHealth CareMedical
SeedSep 11, 2023
Amount Raised: $3,127,013
Thalia Design Automation

Bath, Bath and North East Somerset, United Kingdom

Thalia Design Automation provides software solutions to assist in the design of analog and mixed signal integrated circuits.

ElectronicsSemiconductorSoftware
Series UnknownJul 19, 2023
Amount Raised: $2,716,818
IbisVision

Newhouse, North Lanarkshire, United Kingdom

IbisVision has developed ‘Ring of Sight’ (ROS), a unique eye test that is specifically designed for the early detection of glaucoma.

Health CareLife ScienceMedical Device
Series UnknownMay 11, 2023
Amount Raised: $5,628,433
GenoMe Diagnostics

Belfast, Belfast, United Kingdom

GenoMe Diagnostics develops OvaME product that helps in improvement of status quo of CA125 blood tests.

Health DiagnosticsMedicalProduct Research
SeedMar 3, 2023
Amount Raised: $1,684,977
Circada

Liverpool, Liverpool, United Kingdom

Circada is intended for use in commercial, healthcare, hospitality, and residential developments.

LightingProduct Design
SeedJul 1, 2022
Amount Raised: $423,316